George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

The Financial Prosecutor’s Office has decided to lift the protection status of witnesses in a bribery case involving Swiss pharmaceutical giant Novartis, doctors and public officials following ...

In its upcoming report, Novartis (NVS) is predicted by Wall Street analysts to post quarterly earnings of $1.94 per share, reflecting an increase of 11.5% compared to the same period last year.

Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck ( MRK -0 ...

In a report released on October 22, David Evans from Kepler Capital maintained a Buy rating on Novartis AG (NOVN – Research Report), ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

The company’s shares closed yesterday at $313.74. Welford covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, and Novartis. According to TipRanks, Welford has an average ...

The Philippine Press Institute (PPI) together with Novartis held a hybrid seminar-workshop for journalists entitled “Anatomy ...

The earnings season for the drug and biotech sector kicked off last week when bellwether Johnson & Johnson reported strong ...

With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies ...